Michael Gilman

Michael Gilman serves as Chief Executive Officer at Arrakis Therapeutics. Arrakis Therapeutics operates in the pharmaceuticals sector with approximately 85.0 employees. The company is headquartered in Newton, Massachusetts. Arrakis Therapeutics generates annual revenue of 3400000.0. To date, Arrakis Therapeutics has raised 113000000.0 in total funding, with the most recent round being Series B.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • We have verified contacts for 2 executives at Arrakis Therapeutics.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 CloudFlare Hosting WordPress.org Google Font API Google Tag Manager Mobile Friendly Remote AI

pharmaceutical manufacturing rna-targeted small molecules rsm medicines drug discovery therapeutic applications rna biology biological targets modulatory mechanisms small molecule drugs rna binding clinical development disease modification covalent modifiers targeted rna degradation oral medicines biotech innovation structure-based drug design rna structure-function relationship druggable rna therapeutic target identification collaborative partnerships pipeline expansion rsm toolkit biopharmaceutical collaborations rna-targeting drug platforms rna structural biology drug design workflow highly selective compounds in vitro pharmacology chemical biology small molecule therapeutics structural bioinformatics dynamic modeling rna & disease biological activity therapeutic proteins precision medicine collaborative research patient-centric approach novel therapeutics rna-targeted therapies rsm discovery innovative drug modalities precision oncology multimodal therapeutic strategies rare diseases neuromuscular diseases cardiovascular conditions neurodegenerative diseases genetic medicines neurology oncology rare genetic disorders myotonic dystrophy type 1 cancer treatment cardiovascular diseases biopharmaceuticals oral bioavailability tryst platform pearl-seq platform undruggable targets innovative therapies therapeutic intervention patient impact pharmaceutical partnerships preclinical development systemic delivery cost-efficient manufacturing disease-modifying therapies collaborative approach scientific community venture capital investment transformative medicines pharmaceuticals medical hospital & health care

JM

James Mutamba Chief Business Officer at Arrakis Therapeutics

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

How can I contact Michael Gilman?

Michael Gilman's verified email address is available on MessageCEO. They currently work at Arrakis Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Michael Gilman lead?

Michael Gilman is Chief Executive Officer at Arrakis Therapeutics, a company in the pharmaceuticals sector with 85.0 employees. The company is based in Newton, Massachusetts.

What industry is Michael Gilman in?

Michael Gilman works in the pharmaceuticals industry as Chief Executive Officer at Arrakis Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Michael Gilman's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michael Gilman's profile is kept up-to-date with the latest available information.

Last updated: April 11, 2026